RATinG: Risk Adapted Therapy in Acute GvHD; Investigating the use of Lenzilumab for treating high risk acute graft versus host disease following allogeneic stem cell transplantation

  • Craddock, Charles (Co-Investigator)
  • Bishop, Rebecca (Principal Investigator)
  • Gates, Simon (Researcher)

Project Details

Short titleRATinG: Risk Adapted Therapy in Acute GvHD; Investigating the use of Lenzilumab for treating high risk acute graft versus host disease following allogeneic stem cell transplantation
StatusActive
Effective start/end date1/01/21 → 31/12/25

Funding

  • Humanigen Inc.